Press-release for stocks in the process industries sector

Prices are updated after-hours

sector : Process industries source : Www.fsdpharma.com

save search

FSD Pharma Retracts Prior Press Release Regarding Syneos Health (NASDAQ: SYNH) and Provides Update
Published: 2023-08-04 (Crawled : 02:00) - fsdpharma.com
SYNH | $42.98 0.0% 7.4M

Health Services

| 1.22% | O: -0.07% H: 0.0% C: 0.0%
HUGE | $0.6167 1.22% 29K

Process Industries

| -55.33% | O: -7.25% H: 5.47% C: 4.69%
pharma health update

FSD Pharma Signs Definitive Agreement to Launch UNBUZZD™, a Revolutionary Rapid Alcohol Detoxification Drink
Published: 2023-08-02 (Crawled : 18:00) - fsdpharma.com
KO 4 | $58.06 -0.14% 0.19% 11M

Consumer Non-Durables

| -5.88% | O: -0.34% H: 1.67% C: 0.65%
HUGE | $0.6167 1.22% 29K

Process Industries

| -53.3% | O: 6.06% H: 0.0% C: 0.0%
CELH | $72.51 -1.33% -1.35% 4.1M

Consumer Non-Durables

| -48.4% | O: -3.45% H: 0.0% C: 0.0%
alcohol pharma rapid agreement

FSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stock
Published: 2023-07-10 (Crawled : 17:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries

| -47.75% | O: 2.54% H: 0.83% C: 0.0%
pharma

FSD Pharma Appoints Zeeshan Saeed as Chief Executive Officer, Anthony Durkacz to Serve as Executive Co-Chairman of the Board of Directors
Published: 2023-07-04 (Crawled : 15:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries

| Email alert Add to watchlist
pharma

FSD Pharma grants Celly Nu exclusive rights to revolutionary recreational alcohol misuse technology
Published: 2023-06-23 (Crawled : 14:20) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries

| -56.28% | O: 1.42% H: 0.35% C: -7.69%
CELH | $72.51 -1.33% -1.35% 4.1M

Consumer Non-Durables

| -50.3% | O: 0.09% H: 3.69% C: 1.42%
alcohol pharma grants technology

FSD Pharma Announces Agreement to Grant Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology
Published: 2023-06-20 (Crawled : 13:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries

| -48.19% | O: 0.84% H: 12.5% C: 10.83%
CELH | $72.51 -1.33% -1.35% 4.1M

Consumer Non-Durables

| -49.12% | O: -0.01% H: 1.9% C: -2.13%
alcohol pharma grant technology agreement

FSD Pharma Appoints Former Ontario Minister of Health Doctor Eric Hoskins to Board of Directors
Published: 2023-05-25 (Crawled : 15:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries

| -41.84% | O: 0.94% H: 0.93% C: -3.74%
pharma health

FSD Pharma Announces Receipt of Court Action and Update on Spin-Out and Distribution
Published: 2023-05-12 (Crawled : 07:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries

| Email alert Add to watchlist
pharma distribution update

FSD Pharma Awarded $2.81 Million in Cost Awards From Dr. Raza Bokhari
Published: 2023-05-11 (Crawled : 13:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries

| -44.96% | O: -0.89% H: 0.9% C: -2.7%
pharma awards

FSD Pharma to Present at Sidoti Virtual Investor Conference May 10-11
Published: 2023-05-08 (Crawled : 14:20) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries

| -52.94% | O: -1.53% H: 1.55% C: -5.43%
pharma conference

FSD Pharma Announces Plan to Spin-Out Subsidiary as Distribution to Shareholders; Shareholder Meeting Scheduled for June 29, 2023
Published: 2023-04-12 (Crawled : 17:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries

| -67.89% | O: 1.04% H: 8.25% C: 5.15%
pharma distribution meeting

FSD Pharma Adds Former Celsius Holdings CEO Gerry David to Board of Advisors
Published: 2023-03-30 (Crawled : 13:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries

| -61.94% | O: 1.85% H: 2.42% C: -2.42%
CELH | $72.51 -1.33% -1.35% 4.1M

Consumer Non-Durables

| -18.9% | O: 1.46% H: 1.15% C: -0.54%
pharma ceo celsius

FSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Efficacy Data of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2023 Forum
Published: 2023-02-23 (Crawled : 14:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries

| -65.75% | O: 0.0% H: 2.22% C: 0.0%
treatment pharma research preclinical lucid-21-302 sclerosis

FSD Pharma submitted a Clinical Trial Application for a planed Phase-1 clinical trial for LUCID-MS
Published: 2023-01-20 (Crawled : 11:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries

| -35.78% | O: 0.0% H: 3.15% C: -1.59%
pharma lucid-ms application trial phase 1

FSD Pharma Inc. has received a No Objection Letter from Health Canada
Published: 2023-02-10 (Crawled : 11:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

Process Industries